The equine healthcare market predicted to be worth around USD 752.76 million by the end of 2023
Horse racing and betting, competitive riding, and leisure are all part of the global equestrian market. It supports several secondary markets, the most important of which being equine healthcare. Equine diagnostic, nutritional, and therapeutic items are all part of this sector. The purpose of this report is to research the market for horse healthcare products and determine its future growth. Market expansion is being driven by participants enticed by high return on investment (ROI). The expansion of this market is also fueled by investment from different other geographical locations in horse racing. However, the availability of alternatives to gambling, such as online betting, as well as the dwindling equine population, are limiting the market's growth. This market's emerging sub-divisions will present potential prospects. The Asia-Pacific market may also be considered a developing market, presenting expansion opportunities.
The equine healthcare market was worth
around USD 601.83 million in 2017 and is predicted to be worth around USD
752.76 million by the end of 2023, with a CAGR of about 3.80% between 2017 and
2023.
This market
can be divided into two categories based on therapeutic product types: equine
therapeutics and equine vaccinations. There are a variety of vaccinations,
antibacterial, antiviral, anti-protozoal, laxatives, and dopamine drugs available.
This market
is divided into two types of diagnostic items: horse pregnancy and gestation
diagnostic products and equine genotyping analysis diagnostic products.
This market
is divided into two categories based on supplement product types: equine
performance supplements and equine protection supplements. The use of
performance supplements is increasing, as it is utilized to increase the
horse's speed during races.
This market
can be divided into four regions based on geography: North America, Europe,
Asia-Pacific, and Latin America, and the Caribbean. Due to increased investment
in betting and horse riding, this industry is likely to rise in the
Asia-Pacific area.
Merck Animal
Health, Boehringer Ingelheim Vetmedica, Affymetrix, Elanco Animal Health,
Zoetis (Pfizer Animal Health), Equine Health U.K., and Equine Orthotics and
Prosthetics are among the report's significant firms. As the equine population
declines, these companies are working on producing items to improve equine
health.
The worldwide equine healthcare market is a growing pharmaceutical industry.
Stringent rules are posing obstacles to the market. However, these restrictions
are strategically discussed in this paper, with a focus on the
commercial policies that are accessible for these items. Porter's five forces
model is used to describe the current industrial situation in the study.
Estimates
are based on current market conditions and future potential for the years
2013-2020.
Intelligence
from important market segments gathered from top investment pockets will aid
decision-makers in making strategic decisions.
The growth
drivers and restraints are detailed to understand the elements that
will affect the market's growth.

Comments
Post a Comment